Patient involvement in the development of drugs for rare diseases.
Ensure patient safety and trial integrity during a global pandemic.
Keeping your clinical trial on track in an evolving environment.
Transforming recruitment through patient-centric trials and real-world, real-time data.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
From recruitment of a single clinical professional to managing entire global functions.
ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.
FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.
The COVID-19 pandemic has not only impacted access to healthcare, but also significantly disrupted the conduct of clinical trials investigating therapies intended to treat cardiovascular (CV) diseases.